Literature DB >> 21396990

Sexually diergic hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats.

Natalie E Gentile1, Julie D Andrekanic, Tracy E Karwoski, R Kenneth Czambel, Robert T Rubin, Michael E Rhodes.   

Abstract

Hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine (NIC) are sexually diergic: Female rats have higher adrenocorticotropic hormone (ACTH) and corticosterone (CORT) responses than do males. In the present study we determined HPA responses in male and female rats following single doses of NIC, a single-dose of NIC immediately following continuous NIC for two weeks, and NIC withdrawal by single-dose mecamylamine (MEC) following continuous NIC infusion for two weeks. Blood sampling occurred before and after MEC and NIC administrations for the determination of ACTH and CORT. In accordance with our previous findings, female ACTH and CORT responses to single-dose NIC were greater than male responses. This sex difference remained after single-dose NIC followed continuous NIC infusion, but HPA responses in both sexes were significantly lower in magnitude and duration than in the single-dose NIC alone groups. Sex differences also were observed following NIC withdrawal by MEC: the HPA responses to pretreatment with MEC were significantly higher in magnitude and duration in the continuous NIC groups than in the single-dose NIC groups. These results demonstrate that HPA responses to NIC are reduced and transient following continuous NIC infusion but are enhanced and sustained following NIC withdrawal by MEC after continuous NIC, suggesting that NIC habituation and withdrawal influence the stress responses in a diergic manner. These findings highlight the importance of sex differences in the effect of NIC on HPA axis activity and stress responsiveness, which may have implications for directing NIC-addiction treatment specifically towards men and women.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396990      PMCID: PMC3109189          DOI: 10.1016/j.brainresbull.2011.03.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  76 in total

1.  Plasma levels of arginine vasopressin elevated in patients with major depression.

Authors:  L van Londen; J G Goekoop; G M van Kempen; A C Frankhuijzen-Sierevogel; V M Wiegant; E A van der Velde; D De Wied
Journal:  Neuropsychopharmacology       Date:  1997-10       Impact factor: 7.853

Review 2.  Brain nicotinic receptors: structure and regulation, role in learning and reinforcement.

Authors:  J P Changeux; D Bertrand; P J Corringer; S Dehaene; S Edelstein; C Léna; N Le Novère; L Marubio; M Picciotto; M Zoli
Journal:  Brain Res Brain Res Rev       Date:  1998-05

3.  Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus.

Authors:  S E File; P J Kenny; A M Ouagazzal
Journal:  Behav Neurosci       Date:  1998-12       Impact factor: 1.912

Review 4.  Sex and blood-brain barrier.

Authors:  B Oztaş
Journal:  Pharmacol Res       Date:  1998-03       Impact factor: 7.658

Review 5.  Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review.

Authors:  M E Rhodes; R T Rubin
Journal:  Brain Res Brain Res Rev       Date:  1999-08

6.  Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.

Authors:  B E Hildebrand; G Panagis; T H Svensson; G G Nomikos
Journal:  Neuropsychopharmacology       Date:  1999-10       Impact factor: 7.853

7.  Nicotine increases cytosolic Ca2+ in vasopressin neurons.

Authors:  S Shioda; T Yada; S Muroya; M Takigawa; Y Nakai
Journal:  Neurosci Res       Date:  1997-12       Impact factor: 3.304

Review 8.  Response of the hypothalamo-pituitary-adrenal axis to nicotine.

Authors:  S G Matta; Y Fu; J D Valentine; B M Sharp
Journal:  Psychoneuroendocrinology       Date:  1998-02       Impact factor: 4.905

9.  Nicotine induced up-regulation of nicotinic receptors in CD-1 mice demonstrated with an in vivo radiotracer: gender differences.

Authors:  T Mochizuki; V L Villemagne; U Scheffel; R F Dannals; P Finley; Y Zhan; H N Wagner; J L Musachio
Journal:  Synapse       Date:  1998-09       Impact factor: 2.562

10.  Effects of nicotine on active avoidance learning in rats: sex differences.

Authors:  O Yilmaz; L Kanit; B E Okur; S Pöğün
Journal:  Behav Pharmacol       Date:  1997-06       Impact factor: 2.293

View more
  19 in total

Review 1.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

2.  Amino acid modulation of dopamine in the nucleus accumbens mediates sex differences in nicotine withdrawal.

Authors:  Luis M Carcoba; Rodolfo J Flores; Luis A Natividad; Laura E O'Dell
Journal:  Addict Biol       Date:  2017-09-22       Impact factor: 4.280

3.  Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.

Authors:  Marissa A Smail; Jessica L Soles; Tracy E Karwoski; Robert T Rubin; Michael E Rhodes
Journal:  Brain Res Bull       Date:  2017-11-07       Impact factor: 4.077

Review 4.  Sex-dependent effects of nicotine on the developing brain.

Authors:  Sarah J Cross; Kay E Linker; Frances M Leslie
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  Influence of environmental enrichment on hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine by osmotic mini-pumps, and nicotine withdrawal by mecamylamine in male and female rats.

Authors:  Amanda J Skwara; Tracy E Karwoski; R Kenneth Czambel; Robert T Rubin; Michael E Rhodes
Journal:  Behav Brain Res       Date:  2012-06-13       Impact factor: 3.332

6.  Sex differences in cholinergic systems in the interpeduncular nucleus following nicotine exposure and withdrawal.

Authors:  Victor L Correa; Rodolfo J Flores; Luis M Carcoba; Montserrat C Arreguin; Laura E O'Dell
Journal:  Neuropharmacology       Date:  2019-07-17       Impact factor: 5.250

7.  Nicotine withdrawal increases stress-associated genes in the nucleus accumbens of female rats in a hormone-dependent manner.

Authors:  Oscar V Torres; Joseph A Pipkin; Patrick Ferree; Luis M Carcoba; Laura E O'Dell
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

Review 8.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

9.  A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females.

Authors:  Laura E O'Dell; Oscar V Torres
Journal:  Neuropharmacology       Date:  2013-05-17       Impact factor: 5.250

Review 10.  Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review.

Authors:  MacKenzie R Peltier; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.